Christopher Cano

Overview

Christopher Cano received an average of $805K in total compensation, including $312K in salary, at TFF Pharmaceuticals from 2020 to 2022.

Source: SEC filings on October 4, 2023 and September 21, 2022.

Related executives

We found four more executives who work or worked at TFF Pharmaceuticals.

Harlan Weisman

TFF Pharmaceuticals

Chief Executive Officer

Zamaneh Mikhak

TFF Pharmaceuticals

Chief Marketing Officer

Kirk Coleman

TFF Pharmaceuticals

Chief Financial Officer

Glenn Mattes

TFF Pharmaceuticals

Chief Executive Officer

News

You may also like